Aims: The ACCOMPLISH trial compared the rates of morbidity and mortality from
cardiovascular causes when two different combination therapies were used in patients with …

Large-scale hypertension studies have indicated the benefits of achieving substantial
reductions in blood pressure (BP); however, most patients require combinations of …

ACCOMPLISH is the first trial designed to compare the effects on major fatal and non‐fatal
cardiovascular endpoints of two forms of antihypertensive combination therapy: benazepril …

Background The optimal combination drug therapy for hypertension is not established,
although current US guidelines recommend inclusion of a diuretic. We hypothesized that …

Although multidrug therapy is required in order to achieve good blood pressure control in
many hypertensives, there are no studies directly comparing fixed-dose combinations as …

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure (JNC 7) recommended using a thiazide diuretic as …

The article discusses a study of the use of benazepril plus amlodipine or
hydrochlorothiazide for hypertension in high-risk patients, published in a 2008 issue of the" …

Reducing blood pressure (BP) to target levels is a major priority in preventing clinical events
in hypertension. Typically this requires more than one drug, and recent guidelines on …

Background ACCOMPLISH is the first trial to use combination therapy for the initial treatment
of high‐risk hypertensive patients. The single hypothesis, the combination of …

Combination therapy with benazepril 40 mg and amlodipine 10 mg (B+ A) has been shown
to be more effective than benazepril 40 mg and hydrochlorothiazide (HCTZ) 25 mg (B+ H) in …